论文部分内容阅读
目的观察坦索罗辛改善经尿道前列腺电切术(TURP)患者术后各类疗效指标。方法接受TURP手术治疗的良性前列腺增生症(BPH)患者93例,按接受TURP时间随机分为观察组(46例)及对照组(47例)。观察组术后开始服用坦索罗辛治疗,对照组未服用坦索罗辛。术后2周评估各类疗效指标,包括国际前列腺症状评分(IPSS)、最大尿流率(MFR)、剩余尿量(RU)、并发症发生频次、留置尿管时间及住院总天数。结果观察组术后各种疗效指标均明显优于对照组(均P<0.01或0.05)。结论坦索罗辛可明显改善接受TURP治疗的BPH患者术后疗效,值得临床推广应用。
Objective To observe the effect of tamsulosin in improving the postoperative efficacy of transurethral resection of prostate (TURP). Methods 93 patients with benign prostatic hyperplasia (BPH) treated with TURP were randomly divided into observation group (46 cases) and control group (47 cases) according to the time of TURP. The observation group started tamsulosin treatment after operation, while the control group did not take tamsulosin. Two weeks after the operation, various indexes of efficacy including IPSS, MFR, RU, frequency of complications, duration of indwelling catheter and days of hospitalization were evaluated. Results All the curative effect indexes in the observation group were significantly better than those in the control group (all P <0.01 or 0.05). Conclusion Tamsulosin can significantly improve the postoperative efficacy of TURP-treated BPH patients, which is worthy of clinical application.